Literature DB >> 11583997

Identification of the high affinity binding site in transforming growth factor-beta involved in complex formation with alpha 2-macroglobulin. Implications regarding the molecular mechanisms of complex formation between alpha 2-macroglobulin and growth factors, cytokines, and hormones.

Q Liu1, T Y Ling, H S Shieh, F E Johnson, J S Huang, S S Huang.   

Abstract

The biological activities of transforming growth factor-beta isoforms (TGF-beta(1,2)) are known to be modulated by alpha(2)-macroglobulin (alpha(2)M). alpha(2)M forms complexes with numerous growth factors, cytokines, and hormones, including TGF-beta. Identification of the binding sites in TGF-beta isoforms responsible for high affinity interaction with alpha(2)M many unravel the molecular basis of the complex formation. Here we demonstrate that among nine synthetic pentacosapeptides with overlapping amino acid sequences spanning the entire TGF-beta(1) molecule, the peptide (residues 41-65) containing Trp-52 exhibited the most potent activity in inhibiting the formation of complexes between (125)I-TGF-beta(1) and activated alpha(2)M (alpha(2)M*) as determined by nondenaturing polyacrylamide gel electrophoresis and by plasma clearance in mice. TGF-beta(2) peptide containing the homologous sequence and Trp-52 was as active as the TGF-beta(1) peptide, whereas the corresponding TGF-beta(3) peptide lacking Trp-52, was inactive. The replacement of the Trp-52 with alanine abolished the inhibitory activities of these peptides. (125)I-TGF-beta(3), which lacks Trp-52, bound to alpha(2)M* with an affinity lower than that of (125)I-TGF-beta(1). Furthermore, unlabeled TGF-beta(3) and the mutant TGF-beta(1)W52A, in which Trp-52 was replaced with alanine, were less potent than unlabeled TGF-beta(1) in blocking I(125)-TGF-beta(1) binding to alpha(2)M*. TGF-beta(1) and TGF-beta(2) peptides containing Trp-52 were also effective in inhibiting I(125)-nerve growth factor binding to alpha(2)M*. Tauhese results suggest that Trp-52 is involved in high affinity binding of TGF-beta to alpha(2)M*. They also imply that TGF-beta and other growth factors/cytokines/hormones may form complexes with alpha(2)M* via a common mechanism involving the interactions between topologically exposed Trp and/or other hydrophobic residues and a hydrophobic region in alpha(2)M*.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11583997     DOI: 10.1074/jbc.M105177200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Characterization of protein factor(s) in rat bronchoalveolar lavage fluid that enhance insulin transport via transcytosis across primary rat alveolar epithelial cell monolayers.

Authors:  Rana Bahhady; Kwang-Jin Kim; Zea Borok; Edward D Crandall; Wei-Chiang Shen
Journal:  Eur J Pharm Biopharm       Date:  2008-02-06       Impact factor: 5.571

Review 2.  Agonists and Antagonists of TGF-β Family Ligands.

Authors:  Chenbei Chang
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-08-01       Impact factor: 10.005

3.  Cryo-EM structures reveal the dynamic transformation of human alpha-2-macroglobulin working as a protease inhibitor.

Authors:  Xiaoxing Huang; Youwang Wang; Cong Yu; Hui Zhang; Qiang Ru; Xinxin Li; Kai Song; Min Zhou; Ping Zhu
Journal:  Sci China Life Sci       Date:  2022-06-28       Impact factor: 6.038

4.  Further evidence for increased macrophage migration inhibitory factor expression in prostate cancer.

Authors:  Katherine L Meyer-Siegler; Kenneth A Iczkowski; Pedro L Vera
Journal:  BMC Cancer       Date:  2005-07-06       Impact factor: 4.430

5.  Biological activity differences between TGF-β1 and TGF-β3 correlate with differences in the rigidity and arrangement of their component monomers.

Authors:  Tao Huang; Seth L Schor; Andrew P Hinck
Journal:  Biochemistry       Date:  2014-09-05       Impact factor: 3.162

6.  Recombinant production of human α2-macroglobulin variants and interaction studies with recombinant G-related α2-macroglobulin binding protein and latent transforming growth factor-β2.

Authors:  Laura Marino-Puertas; Laura Del Amo-Maestro; Marta Taulés; F Xavier Gomis-Rüth; Theodoros Goulas
Journal:  Sci Rep       Date:  2019-06-24       Impact factor: 4.379

7.  Transcriptome profiling of posterior kidney of brown trout, Salmo trutta, during proliferative kidney disease.

Authors:  Arun Sudhagar; Reinhard Ertl; Gokhlesh Kumar; Mansour El-Matbouli
Journal:  Parasit Vectors       Date:  2019-11-29       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.